— Know what they know.
Not Investment Advice
Also trades as: INCR.TA (TLV) · $vol 0M

INCR NASDAQ

InterCure Ltd.
1W: +4.0% 1M: +0.4% 3M: +8.4% YTD: +5.2% 1Y: -34.3% 3Y: -30.5% 5Y: -84.7%
$5.42
+0.05 (+0.93%)
 
Weekly Expected Move ±4.9%
$5 $5 $5 $6 $6
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 57 · $64.2M mcap · 8M float · 0.274% daily turnover · Short 14% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$64.2M
52W Range3.4-8.45
Volume2,953
Avg Volume20,851
Beta0.59
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOAlexander Rabinovich
Employees285
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2019-01-28
85 Medinat ha-Yehudim Street
Herzliya, TA 4676670
IL
972 7 7460 5012
About InterCure Ltd.

InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.

Recent Insider Trades

NameTypeSharesPriceDate
Cohen Amos A-Award 590,000 $1.00 2026-06-09
Michelson Lennie Gri 0 — 2026-03-18
Rabinovich Alexander 0 — 2026-03-18
Rabinovich Alexander 0 — 2026-03-18
Rabinovich Alexander 0 — 2026-03-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms